John Xu
Directeur Général chez Jemincare Therapeutics Corp.
Postes actifs de John Xu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Jemincare Therapeutics Corp.
 Jemincare Therapeutics Corp. BiotechnologyHealth Technology Jemincare Therapeutics Corp. is a pharmaceutical company. It plans to in license the global and China rights of the large and small molecule clinical stage programs in therapeutic areas such as oncology, cardiovascular and kidney disease. The company was founded by John Xu in November 2018 and is headquartered in Princeton, NJ. | Directeur Général | 01/11/2018 | - |
| Fondateur | 01/11/2018 | - |
Historique de carrière de John Xu
Anciens postes connus de John Xu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ABPRO CORPORATION | Corporate Officer/Principal | 01/10/2019 | - |
Formation de John Xu
| Zhongshan Hospital Fudan University | Doctorate Degree |
| University of Colorado Colorado Springs | Masters Business Admin |
| Chicago Medical School | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Chine | 2 |
| 2 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
Jemincare Therapeutics Corp.
Jemincare Therapeutics Corp. BiotechnologyHealth Technology Jemincare Therapeutics Corp. is a pharmaceutical company. It plans to in license the global and China rights of the large and small molecule clinical stage programs in therapeutic areas such as oncology, cardiovascular and kidney disease. The company was founded by John Xu in November 2018 and is headquartered in Princeton, NJ. | Health Technology |